Puma Biotechnology Cash Flow Statement (2017-2025) | PBYI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	16.53M	-5.11M	-44.67M	4.22M	-3.40M	9.37M	-0.36M	-5.61M	1.40M	2.13M	5.80M	12.27M	-4.82M	-4.53M	20.32M	12.95M	2.97M	5.86M	8.84M	-17.67M
Depreciation and Depletion (Quarter)	0.20M	0.20M	0.20M	0.10M	0.20M	0.10M	0.20M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M
Share-based Compensation (Quarter)	5.86M	18.24M	4.28M	-14.78M	3.15M	3.22M	2.83M	2.63M	2.84M	2.43M	2.54M	2.43M	2.38M	2.06M	2.05M	1.75M	2.03M	1.63M	1.67M	1.62M
Gains from Sales and Divestitures (Quarter)	0.24M	0.65M	0.77M	1.09M	0.19M	0.51M	0.85M	1.02M	0.32M	0.60M	1.20M	1.30M	0.57M	0.81M	1.36M	1.39M	0.51M	0.73M	1.22M	1.25M
Gains from Investment Securities (Quarter)		0.53M	-0.00M	-0.00M	-0.00M	0.48M	0.58M		0.58M	0.58M	0.58M		0.44M	0.44M	0.11M	-0.44M	0.64M	2.98M	0.08M	0.20M
Asset Writedowns and Impairment (Quarter)										0.51M	0.11M	0.28M	0.10M	-0.20M	-0.10M	-0.42M	0.21M	-0.30M	-0.10M	0.40M
Non-cash Items (Quarter)	4.33M	2.53M	1.08M		3.39M	0.25M	3.59M	1.05M	0.38M	3.58M	0.14M	1.10M	2.20M	3.97M	3.89M	0.31M	0.35M	3.58M	3.15M	3.61M
Cash from Operations (Quarter)	15.66M	-0.07M	10.50M	-5.43M	-26.89M	-13.87M	17.26M	7.68M	2.64M	3.30M	10.62M	10.46M	11.25M	1.03M	11.04M	15.61M	3.60M	14.09M	9.71M	14.40M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	2.95M	2.94M	2.44M	2.98M	2.46M	2.46M	2.47M	2.45M	2.88M	2.88M	2.88M	2.89M	2.90M	2.91M	2.88M	2.84M	2.80M	2.76M	2.72M	2.66M
Change in Working Capital
Change in Receivables (Quarter)	0.61M	3.39M	-6.75M	8.73M	-5.49M	6.95M	-5.96M	12.32M	-9.19M	0.64M	-2.32M	19.23M	-23.14M	3.34M	26.49M	-23.03M	-6.63M	0.38M	7.44M	20.09M
Change in Inventory (Quarter)	4.29M	-0.12M	-0.41M	-0.10M	0.17M	-0.61M	-1.21M	-0.93M	-0.64M	3.74M	-1.95M	1.40M	0.02M	1.95M	-6.38M	6.05M	0.03M	-0.16M	0.89M	-3.96M
Change in Account Payables (Quarter)	-1.42M	0.51M	8.88M	-8.87M	-3.76M	2.43M	5.09M	-8.49M	2.15M	-0.79M	-2.73M	1.83M	2.08M	4.54M	-5.99M	-2.00M	0.52M	-0.60M	0.96M	-1.33M
Change in Accured Expenses (Quarter)	-6.56M	-11.95M	22.22M	1.50M	-30.90M	-21.26M	-1.61M	20.70M	-18.81M	1.45M	-1.55M	11.33M	-15.01M	1.29M	11.66M	-13.76M	-9.88M	4.88M	5.28M	12.88M
Other Working Capital Changes (Quarter)	-0.09M	0.19M	0.74M	-0.00M	0.55M	0.62M	0.72M	0.79M	-0.87M	0.10M	0.10M	-0.14M	-0.41M	0.11M	0.36M	-0.32M	0.01M	0.22M	0.85M	0.03M
Investing Activities
Capital Expenditures (Quarter)											-0.01M	0.03M		0.02M		-0.02M	0.06M	0.02M	0.03M	-0.10M
Change in Intangibles (Quarter)									12.50M
Change in Acquisitions & Divestments (Quarter)	5.39M	2.69M	14.49M	4.62M	8.98M	2.00M	8.00M	-0.04M		0.98M	13.17M	3.18M	5.89M	20.64M	16.34M	12.97M	14.10M	10.69M	27.32M	19.92M
Cash from Investing Activities (Quarter)	-5.30M	-5.73M	-4.47M	4.62M	8.98M	2.00M	8.00M	-11.87M	-17.45M	-4.68M	11.18M	-8.17M	-19.08M	0.70M	0.26M	-2.32M	1.53M	-11.25M	0.51M	-26.98M
Financing Activities
Other financing activities (Quarter)				1.91M	0.15M		0.05M	0.07M
Cash from Financing Activities (Quarter)			-31.93M	-0.00M	9.85M		-0.05M	2.43M						-11.33M	-11.18M	-11.33M	-11.33M	-11.20M	-11.33M	-11.33M
Additional items
Change in Cash (Quarter)	10.36M	-5.80M	-25.90M	-0.82M	-8.07M	-11.88M	25.20M	-1.76M	-14.81M	-1.39M	21.79M	2.29M	-7.83M	-9.60M	0.11M	1.96M	-6.19M	-8.37M	-1.14M	-23.89M
Free Cash Flow (Quarter)	15.66M	-0.07M	10.50M	-5.43M	-26.89M	-13.87M	17.26M	7.68M	2.64M	3.30M	10.63M	10.43M	11.25M	1.01M	11.04M	15.63M	3.54M	14.07M	9.68M	14.50M
Net Cash Flow (Quarter)	10.36M	-5.80M	-25.90M	-0.82M	-8.07M	-11.88M	25.20M	-1.76M	-14.81M	-1.39M	21.79M	2.29M	-7.83M	-9.60M	0.11M	1.96M	-6.20M	-8.36M	-1.12M	-23.91M

Research Tools

Puma Biotechnology Cash Flow Statement (2017-2025) | PBYI

Create an account

Sign In

Reset Password